Minimal Dataset used for analysis.

This table contains the data used in this analysis for each participant. Variables: ID, participant number; Age, in years; Gender; Ethnicity; Race; TxArm, EFV/FTC/TDF for efavirenz/emtricitabine/tenofovir disoproxil fumarate or ATV/r/FTC/TDF for atazanavir/ritonavir/emtricitabine/tenofovir disoproxil fumarate; Tobacco use; Alcohol use; CD4, screening visit CD4+ T-cell count, in cells/mm3; BMI, body mass index, in kg/m2; CrCL, calculated creatinine clearance, in mL/hr; Frailty Phenotype, positive or negative; Frailty Yes, number of positive frailty phenotype components; individual cytokine concentrations, in pg/mL; CD4:CD8 ratio; log2 p16INK4a expression; individual regimen component calculated AUC (area under the curve) values for FTC (emtricitabine, in ng*hr/mL), ATV (atavanavir, in ng*hr/mL), EFV (efavirenz, in ng*hr/mL), RTV (ritonavir, in ng*hr/mL), TFV (tenofovir, in ng*hr/mL), FTCtp (emtricitabine triphosphate, in fmol*hr/million cells), TFVdp (tenofovir diphosphate, in fmol*hr/million cells), dATP (deoxyadenosine triphosphate, in fmol*hr/million cells), dCTP (deoxycytidine triphosphate, in fmol*hr/million cells), EFV_u (unbound efavirenz, in ng*hr/mL), ATV_u (unbound atazanavir, in ng*hr/mL), RTV_u (unbound ritonavir, in ng*hr/mL); unbound fraction (fu) values (as percentage) for EFV, ATV, and RTV.
(XLSX)